This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Non-melanomatous Skin Cancer, Pancreatic Cancer, Small Intestine Cancer or Testicular Germ Cell Tumor
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is evaluating a tumor marker for testicular cancer, skin cancer, small intestine cancer, and pancreatic cancer.

Provided treatments

  • Genetic: in situ hybridization
  • Genetic: protein expression analysis
  • Other: immunologic technique

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT00899132. The sponsor of the trial is Case Comprehensive Cancer Center and it is looking for 180 volunteers for the current phase.
Official trial title:
The Role of TAB3 Protein in Tumorigenesis